http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2626801-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 |
| filingDate | 2012-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94db340f489be26a21d28a776465b728 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45590828fce09c7cdec31e2339d1a132 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_423391ae9c312a6da87d7a66e0bc7311 |
| publicationDate | 2017-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2626801-T3 |
| titleOfInvention | Triazolopyridine compounds as pde10a inhibitors |
| abstract | A compound of formula (I) ** Formula ** in which R 1 is aryl, heteroaryl or NR 4 R 5, wherein said aryl and said heteroaryl may be substituted with 1 to 3 substituents independently selected from the group consisting of hydroxyl, halogen, C1-C7 alkyl, C1-C7 alkoxy and C1-C7 haloalkyl; R2 is hydrogen, halogen or C1-C7 alkyl; R3 is aryl or heteroaryl, wherein said aryl and said heteroaryl may be substituted with 1 to 3 substituents independently selected from the group consisting of C1-C7 alkyl, hydroxyl, halogen, -C (O) -NR6R7 and -C (O ) -O-R8; R4 and R5 are independently C1-C7 alkyl, C3-C8 cycloalkyl, together with the nitrogen atom to which they are attached, form a heterocycloalkyl which may be substituted with 1 to 3 substituents independently selected from the group consisting of hydroxyl, halogen, alkyl C1-C7, C1-C7 alkoxy and C1-C7 haloalkyl; R6 and R7 are independently C1-C7 alkyl, C3-C8 cycloalkyl, together with the nitrogen atom to which they are attached, form a heterocycloalkyl which may be substituted with 1 to 3 substituents independently selected from the group consisting of hydroxyl, halogen, alkyl C1-C7, C1-C7 alkoxy and C1-C7 haloalkyl; R8 is hydrogen, C1-C7 alkyl, cycloalkyl; or a pharmaceutically acceptable salt thereof. |
| priorityDate | 2011-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310 |
Total number of triples: 30.